Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma, IDH-wildtype

Explore clinical trials studying Glioblastoma, IDH-wildtype. Study availability and eligibility vary by location and protocol.

35 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma, IDH-wildtype trial results

Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

NCT05879367

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, GBM, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Columbia University Medical Center - Herbert Irving Pavilion New York, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Recruiting

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

NCT06283927

Conditions
Astrocytoma, Astrocytoma of Brain, Astrocytoma, Malignant, +14 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Hospital Leuven Leuven, Belgium
  • University Hospital Heidelberg Heidelberg, Germany
View Trial Details
Recruiting

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

NCT06273176

Conditions
Astrocytoma, Astrocytoma, Malignant, Brain Diseases, +25 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Hospital Leuven Leuven, Belgium
  • Universitätsklinikum Heidelberg Heidelberg, Germany
View Trial Details
Recruiting

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

NCT06118723

Conditions
Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +24 more
Locations
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Hospitals Leuven Leuven, Belgium
  • Universitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
View Trial Details

Related conditions